CN103535725A - 一种果蔬保健品及其制备方法 - Google Patents
一种果蔬保健品及其制备方法 Download PDFInfo
- Publication number
- CN103535725A CN103535725A CN201310494195.5A CN201310494195A CN103535725A CN 103535725 A CN103535725 A CN 103535725A CN 201310494195 A CN201310494195 A CN 201310494195A CN 103535725 A CN103535725 A CN 103535725A
- Authority
- CN
- China
- Prior art keywords
- powder
- fruit
- parts
- preparation
- vegetables
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000012055 fruits and vegetables Nutrition 0.000 title claims abstract description 24
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- 238000004519 manufacturing process Methods 0.000 title description 6
- 239000000843 powder Substances 0.000 claims abstract description 69
- 235000009337 Spinacia oleracea Nutrition 0.000 claims abstract description 17
- 240000003259 Brassica oleracea var. botrytis Species 0.000 claims abstract description 15
- 235000000832 Ayote Nutrition 0.000 claims abstract description 14
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 claims abstract description 14
- 235000009854 Cucurbita moschata Nutrition 0.000 claims abstract description 14
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 claims abstract description 14
- 235000015136 pumpkin Nutrition 0.000 claims abstract description 14
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims abstract description 13
- 240000003768 Solanum lycopersicum Species 0.000 claims abstract description 13
- 239000000463 material Substances 0.000 claims abstract description 12
- 239000002994 raw material Substances 0.000 claims abstract description 4
- 240000004244 Cucurbita moschata Species 0.000 claims abstract 2
- 244000300264 Spinacia oleracea Species 0.000 claims abstract 2
- 230000036541 health Effects 0.000 claims description 19
- 244000017020 Ipomoea batatas Species 0.000 claims description 15
- 235000002678 Ipomoea batatas Nutrition 0.000 claims description 15
- 235000012054 meals Nutrition 0.000 claims description 12
- 239000003814 drug Substances 0.000 claims description 10
- 239000002775 capsule Substances 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 7
- 239000008187 granular material Substances 0.000 claims description 6
- 239000006187 pill Substances 0.000 claims description 6
- 229940079593 drug Drugs 0.000 claims description 5
- 239000003826 tablet Substances 0.000 claims description 5
- 239000004480 active ingredient Substances 0.000 claims description 2
- 239000000853 adhesive Substances 0.000 claims description 2
- 230000001070 adhesive effect Effects 0.000 claims description 2
- 238000007796 conventional method Methods 0.000 claims description 2
- 238000011049 filling Methods 0.000 claims description 2
- 239000000314 lubricant Substances 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 239000000047 product Substances 0.000 abstract description 26
- 206010028980 Neoplasm Diseases 0.000 abstract description 20
- 230000000694 effects Effects 0.000 abstract description 15
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract description 10
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract description 8
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 abstract description 6
- 239000011669 selenium Substances 0.000 abstract description 6
- 229910052711 selenium Inorganic materials 0.000 abstract description 6
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 abstract description 5
- 229910052742 iron Inorganic materials 0.000 abstract description 5
- 239000011701 zinc Substances 0.000 abstract description 5
- 229910052725 zinc Inorganic materials 0.000 abstract description 5
- 241000352057 Solanum vernei Species 0.000 abstract description 4
- 235000004976 Solanum vernei Nutrition 0.000 abstract description 4
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 abstract description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 3
- 229910052804 chromium Inorganic materials 0.000 abstract description 3
- 239000011651 chromium Substances 0.000 abstract description 3
- 229910052802 copper Inorganic materials 0.000 abstract description 3
- 239000010949 copper Substances 0.000 abstract description 3
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 abstract description 3
- 235000016709 nutrition Nutrition 0.000 abstract description 3
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 abstract description 2
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 abstract description 2
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 abstract description 2
- 238000010521 absorption reaction Methods 0.000 abstract description 2
- 239000003963 antioxidant agent Substances 0.000 abstract description 2
- 235000006708 antioxidants Nutrition 0.000 abstract description 2
- 239000010941 cobalt Substances 0.000 abstract description 2
- 229910017052 cobalt Inorganic materials 0.000 abstract description 2
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 abstract description 2
- 235000012661 lycopene Nutrition 0.000 abstract description 2
- 239000001751 lycopene Substances 0.000 abstract description 2
- 229960004999 lycopene Drugs 0.000 abstract description 2
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 abstract description 2
- 229910052750 molybdenum Inorganic materials 0.000 abstract description 2
- 239000011733 molybdenum Substances 0.000 abstract description 2
- 230000035764 nutrition Effects 0.000 abstract description 2
- 239000013589 supplement Substances 0.000 abstract description 2
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 abstract description 2
- SUVMJBTUFCVSAD-UHFFFAOYSA-N sulforaphane Chemical compound CS(=O)CCCCN=C=S SUVMJBTUFCVSAD-UHFFFAOYSA-N 0.000 abstract 2
- SUVMJBTUFCVSAD-JTQLQIEISA-N 4-Methylsulfinylbutyl isothiocyanate Natural products C[S@](=O)CCCCN=C=S SUVMJBTUFCVSAD-JTQLQIEISA-N 0.000 abstract 1
- 108010064851 Plant Proteins Proteins 0.000 abstract 1
- 235000010208 anthocyanin Nutrition 0.000 abstract 1
- 239000004410 anthocyanin Substances 0.000 abstract 1
- 229930002877 anthocyanin Natural products 0.000 abstract 1
- 150000004636 anthocyanins Chemical class 0.000 abstract 1
- 229960005070 ascorbic acid Drugs 0.000 abstract 1
- 235000010323 ascorbic acid Nutrition 0.000 abstract 1
- 239000011668 ascorbic acid Substances 0.000 abstract 1
- 150000001746 carotenes Chemical class 0.000 abstract 1
- 235000005473 carotenes Nutrition 0.000 abstract 1
- 235000021118 plant-derived protein Nutrition 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 229960005559 sulforaphane Drugs 0.000 abstract 1
- 235000015487 sulforaphane Nutrition 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 description 18
- 241000219315 Spinacia Species 0.000 description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- 240000001980 Cucurbita pepo Species 0.000 description 12
- 230000003203 everyday effect Effects 0.000 description 12
- 230000001093 anti-cancer Effects 0.000 description 11
- 238000005516 engineering process Methods 0.000 description 10
- 241000699660 Mus musculus Species 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 238000011580 nude mouse model Methods 0.000 description 8
- 229930014669 anthocyanidin Natural products 0.000 description 7
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 7
- 235000008758 anthocyanidins Nutrition 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 6
- 208000005718 Stomach Neoplasms Diseases 0.000 description 6
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- -1 carrotene Substances 0.000 description 5
- 201000000498 stomach carcinoma Diseases 0.000 description 5
- 240000002853 Nelumbo nucifera Species 0.000 description 4
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 4
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 4
- 208000009956 adenocarcinoma Diseases 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 235000019169 all-trans-retinol Nutrition 0.000 description 3
- 239000011717 all-trans-retinol Substances 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 229960004857 mitomycin Drugs 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 239000011648 beta-carotene Substances 0.000 description 2
- 229960002747 betacarotene Drugs 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000000973 chemotherapeutic effect Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- UWBHHFACDVJLQC-UHFFFAOYSA-N spinacetin Chemical group COc1c(O)cc2OC(=C(O)C(=O)c2c1O)c3ccc(O)c(C)c3 UWBHHFACDVJLQC-UHFFFAOYSA-N 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- MOMFXATYAINJML-UHFFFAOYSA-N 2-Acetylthiazole Chemical group CC(=O)C1=NC=CS1 MOMFXATYAINJML-UHFFFAOYSA-N 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- 229940123457 Free radical scavenger Drugs 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- KDLBPPXQNXUTGJ-UHFFFAOYSA-N Patuletin Chemical group C1=C(OC)C(OC)=CC=C1C1=C(O)C(=O)C2=C(O)C(OC)=C(O)C=C2O1 KDLBPPXQNXUTGJ-UHFFFAOYSA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Natural products OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- XWIDINOKCRFVHQ-UHFFFAOYSA-N Spinacetin Chemical group C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C(OC)=C(O)C=C3O2)O)=C1 XWIDINOKCRFVHQ-UHFFFAOYSA-N 0.000 description 1
- YCFJXOFFQLPCHD-UHFFFAOYSA-N Spinacin Natural products C1NC(C(=O)O)CC2=C1NC=N2 YCFJXOFFQLPCHD-UHFFFAOYSA-N 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 108010076830 Thionins Proteins 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- JZVFJDZBLUFKCA-FXIAWGAOSA-N alpha-Spinasterol Chemical group C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)CC[C@H]33)C)C3=CC[C@H]21 JZVFJDZBLUFKCA-FXIAWGAOSA-N 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000008499 blood brain barrier function Effects 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical group 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical group C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- JMIFIYIEXODVTO-UHFFFAOYSA-N patuletin Chemical group OC=1C(=O)C2=C(O)C(OC)=C(O)C=C2OC=1C1=CC=C(O)C(O)=C1 JMIFIYIEXODVTO-UHFFFAOYSA-N 0.000 description 1
- 201000001245 periodontitis Diseases 0.000 description 1
- 229960003742 phenol Drugs 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 125000003748 selenium group Chemical group *[Se]* 0.000 description 1
- 150000003384 small molecules Chemical group 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 235000020985 whole grains Nutrition 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/09—Mashed or comminuted products, e.g. pulp, purée, sauce, or products made therefrom, e.g. snacks
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
本发明涉及保健品,特别是一种果蔬保健品及其制备方法。该果蔬保健品,其特殊之处在于:主要由以下重量份数的原料制备:紫薯粉10-70份、花椰菜粉80-120份、南瓜粉30-80份、菠菜粉10-40份、番茄粉20-70份。产品成分以抗坏血素,萝葡硫素,高植物蛋白,胡萝卜素,抗氧化剂,番茄红素,花青素,铁,锌,碘,铜,铬,钼,钴和硒等大量微量元素组成,不仅能调节机体功能,而且具有防癌、抗癌的功效,配方简单,取材广泛,易吸收等优点。特别适用于需要平衡补充身体营养的各类人群。
Description
(一) 技术领域
本发明涉及保健品,特别一种果蔬保健品及其制备方法。
(二) 背景技术
癌症的死亡率极高,癌症早期治疗率较高,但是早期症状往往很少,很难引起人们的重视,待发展到一定阶段,一般是中、后期后才渐渐表现出一系列症状和体征,这时往往错过了最佳治疗时间。
做好癌症的预防工作尤为重要,如食用具有抗癌作用的食物进行癌症的预防,但是随之工作节奏的加快、压力的加大,人们没有太多的精力放在这上面,因此实现起来很困难。
面对癌症发病率越来越高的今天,需要一种服用方便,并且具有防癌、抗癌功效的产品。保健品是一种很好的选择,其食用、携带方便,是按照人体所需要的营养物质成份,从天然植物、蔬菜、水果及奶制品等物质成份提取制作而成,对人体的使用来说可以按清、调、补三个方面分类配制,具有特殊功能的产品。
(三) 发明内容
本发明为了弥补现有技术的不足,提供了一种无刺激、无副作用、绿色的防癌果蔬保健品及其制备方法。
本发明是通过如下技术方案实现的:
一种果蔬保健品,其特殊之处在于:主要由以下重量份数的原料制备:
紫薯粉 10-70份、花椰菜粉 80-120份、南瓜粉30-80份、菠菜粉 10-40份、番茄粉 20-70份。
本发明的果蔬保健品的制备方法,包括以下步骤:将其原药材和/或其有效成分和/或药学上可接受的辅料一起制成散剂或袋泡剂、口服液、胶囊剂、片剂、丸剂或颗粒剂。
本发明的果蔬保健品的制备方法,将上述果蔬粉经粉碎、过筛、混合均匀,不加辅料直接灌胶囊或按常规方法制备保健药剂,或是加入适当辅料、并加入粘合剂制粒,干燥后灌装胶囊或加适量润滑剂后压成片剂。
服用方法:一日二次,每日服用1.5-3g。坚持每天服用有助于平衡身体所需营养成分。
下面为本发明中各药材的功能及作用:
紫薯粉:紫薯的营养成分含量明显高于普通的红薯,其赖氨酸、铜、锰、钾、锌的含量高于一般红薯的3-8倍,长期食用具有降压、补血、益气、润肺、养颜之功效;同时,它属于减肥食品,能够有效预防动脉硬化,尤其是抗癌质碘、硒的含量比其他红薯高20倍以上。而硒和铁是人体抗疲劳、抗衰老、补血的必要元素,特别是硒被称为“抗癌大王”,易被人体吸收,可留在血清中,修补心肌,增强机体免疫力,清除体内自由基,抑制癌细胞中DNA的合成和癌细胞的分裂与生长,预防胃癌、肝癌等癌症的发生。传统中医认为:“黑色补肾,肾为先天之体,生命之源固于肾”,现代医学认为“黑色食品”不但营养丰富,且多有补肾,防衰老,保健益寿,防病治病,乌发美容等独特功效。紫薯所含大量功效奇特、药用价值高的花青素。根据《健康研究》一书中,法国科学家马斯魁勒博士发现花青素是天然强效自由基清除剂,其清除自由基能力是维生素C的20倍,维生素E的50倍,花青素具有小分子结构,是唯一能透过血脑屏障清除自由基保护大脑细胞的物质,同时能减少抗生素给人体的一些危害,紫薯将成为花青素的主要原料之一。经各国科学家实验证明,花青素对100多种疾病有预防和治疗作用,如有助于预防多种与自由基有关的疾病,包括癌症、心脏病、过早衰老和关节炎,花青素被誉为继水、蛋白质、脂肪、碳水化合物、维生素、矿物质之后的第七大必须营养素。
花椰菜粉:有强肾壮骨、补脑填髓、健脾养胃、清肺润喉作用。它所含的多种维生素、纤维素、胡萝卜素、微量元素硒都对抗癌、防癌有益。
南瓜粉:性味:温,甘。功用:补中益气。化痰排脓。南瓜粉性胃肝、入脾、胃经。具有补中益气、消炎止痛、化痰排脓、解毒杀虫功能、生肝气、益肝血 。成份:铬、镍、纤维、蛋白质、胡萝卜素、维他命A、氨基酸(胡卢巴碱、腺嘌呤、精氨酸、瓜氨酸、天门冬素、多缩戍糖等)、矿物质(钾、磷、钙、铁、锌、硒等)、碳水化合物、淀粉、维生素B1、B2、C、F等、镁。治疗疾病:防癌、杜虫、治高血压、治哮喘、治久咳、治浮肿、腹水、小便不畅、治惯性流产、治烧伤、烫伤、治支气管哮喘及老年慢性支气管炎、治痢疾、止痛、治糖尿病、治热燥性症候、治肾脏病、防神经性脱发、壮阳、精强、预防男性前列腺肿胀。
菠菜粉:菠菜指植物菠菜的带根全草,营养价值丰富,菠菜叶含锌56~68毫克/公斤,叶酸1.22微克/克,氨基酸和叶黄素、β-胡萝卜素、新-β-胡萝卜素B、新-β-胡萝卜素;另外,含菠菜素U等类胡萝卜素、α-菠菜甾醇、胆甾醇、甾醇酯和甾醇甙、万寿菊素、菠叶素和2-乙酰基-3-对羟基苯丙烯酰基内消旋酒石酸。菠菜含有丰富的维他命A、维他命C及矿物质,尤其维他命A、维他命C含量是所有蔬菜类之冠,人体造血物质铁的含量也比其它蔬菜为多,对于胃肠障碍、便秘、痛风、皮肤病、各种神经疾病、贫血确有特殊食疗效果。对解酒毒及防止齿槽脓漏现象亦具有食疗神效。常食菠菜,具有通便清热、理气补血、防病抗衰等功效,它对各种贫血症和糖尿病、肺结核、高血压、风火赤眼等诸多疾病可起辅助治疗作用。
番茄粉:味酸;甘;性微寒。清热止渴,养阴凉血、生津止渴,可有效的 治皮肤病、治高血压、治贫血、防中暑、退高烧、治牙龈出血、治口渴、食欲不振、治夜盲症、治疗口疮、而且具有较强的清热解毒、抑制病变功效,可起到防癌和辅助治疗癌症的作用。
本发明的有益效果是:紫薯粉、花椰菜粉、南瓜粉、番茄粉均具有防癌、抗癌的功效,辅以菠菜粉,产品成分以抗坏血素,萝葡硫素,高植物蛋白,胡萝卜素,抗氧化剂,番茄红素,花青素,铁,锌,碘,铜,铬,钼,钴和硒等大量微量元素组成,不仅能调节机体功能,而且具有防癌、抗癌的功效,配方简单,取材广泛,易吸收等优点。特别适用于需要平衡补充身体营养的各类人群。
(四) 具体实施方式
实施例1 :
配方:紫薯粉 10g、花椰菜粉 80g、南瓜粉30g、菠菜粉 10g、番茄粉 70g。
制备工艺:将果蔬粉加其重8倍量的水煎煮3次,合并煎液,浓缩至相对密度为1.23 (50℃)的稠膏,然后制粒、干燥、制得胶囊,每粒装2g。每日服用2次,每次服用1粒。
实施例2:
配方:紫薯粉 40g、花椰菜粉 120g、南瓜粉80g、菠菜粉 40g、番茄粉 45g。
制备工艺:将上述果蔬粉混合均匀,直接灌胶囊,每粒装1.5g。每日服用2次,每次服用1粒。
实施例3:
配方:紫薯粉 25g、花椰菜粉 100g、南瓜粉50g、菠菜粉 25g、番茄粉 70g。
制备工艺:将果蔬粉中加其重8倍量的50%乙醇提取3次,合并提取液,回收乙醇,浓缩至相对密度为1.27 (50℃)的稠膏,加入淀粉40g,混合均匀,制粒、干燥,压片,每片重1.8g。每日服用2次,每次服用1片。
实施例4:
配方:紫薯粉 70g、花椰菜粉 100g、南瓜粉70g、菠菜粉 30g、番茄粉20g。
制备工艺:将果蔬粉中加其重12倍量的70%乙醇提取2次,合并提取液,回收乙醇,浓缩至相对密度为1.22 (50℃)的稠膏,泛法制丸并抛光,制成浓缩丸,每丸重1.8g。每日服用2次,每次服用1丸。
实施例5:
配方:紫薯粉 25g、花椰菜粉120g、南瓜粉50g、菠菜粉 25g、番茄粉 60g。
制备工艺:将上述果蔬粉混合均匀,直接灌胶囊或按水丸生产工艺制成为水丸,每丸重1.5g。每日服用2次,每次服用1粒。
实施例6:
配方:紫薯粉20g、花椰菜粉 80g、南瓜粉50g、菠菜粉 25g、番茄粉 40g。
制备工艺:将上述果蔬粉混合加入其重8倍量的水,分两次煎煮,第一次2h,第二次1h,合并煎液,趁热滤过,上清液浓缩至含生药量为1g/ml的浓缩液,浓缩液降温至室温后,在浓缩液中加入重量6-10倍的质量浓度60%的乙醇,密闭冷藏12h,过滤除去杂质,滤液回收乙醇,得到精制液,往精制液中加纯化水至每1ml口服液相当于果蔬粉1g,搅拌均匀,过滤,灌封,灭菌,即制备成口服液(每瓶口服液体积为2ml)。每日服用2次,每次服用1瓶。
实施例7:
配方:紫薯粉10g、花椰菜粉80g、南瓜粉50g、菠菜粉 30g、番茄粉 70g。
制备工艺:将上述果蔬粉药材,过40目筛,制成散剂或袋泡剂,每日服用2次,每次服用1.5g。
实施例8:
配方:紫薯粉 10g、花椰菜粉 110g、南瓜粉50g、菠菜粉 25g、番茄粉 70g。
制备工艺:将上述果蔬粉过80目筛后加入其重总重8倍的水,分两次煎煮,第一次2小时,第二次1小时,合并煎液,趁热滤过,所得上清液浓缩至相对密度为1.30(50℃)的稠膏,按稠膏中加入乳糖40g,混合均匀,制成颗粒,在60℃条件下干燥,整粒,包装,每包净重2g,每日服用2次,每次服用1包。
上述花椰菜粉可选用上虞市万事达麦业有限公司食品级纯天然脱水西兰花椰菜粉,2012年8月6日购入。
实施例9:
用上述本发明的保健品通过裸鼠分别对癌症做实验,得知本发明保健品对癌症具有明显的抗癌作用。
现以用上述本发明的保健品分别对人胃低分化腺癌SGC-7901 以及人胃高分化腺癌MKN-28 裸鼠原位移植模型进行治疗为例。实验分3 组:本发明药物高浓度组(4800mg/kg·bw)以及阳性对照组( 丝裂霉素C1mg/kg·bw) 和阴性对照组( 生理盐水)。本发明药物灌胃给药,每天2 次,连续给药40 次,丝裂霉素C 皮下注射给药,每2 天1 次,共给药10 次,实验以荷人胃癌裸鼠的生命延长率、胃指数、血清唾液酸(SA) 含量作为疗效评价指标。实验重复3 次。
本发明保健品对荷人胃癌SGC-7901裸鼠生命延长率为57.70% -71.92% (P < 0.01) ,阳性对照丝裂霉素C 对荷人胃癌SGC-7901 裸鼠生命延长率为52.75% -60.00% (P < 0.01) ;服用本发明保健品治疗后,荷人胃癌MKN-28 裸鼠的胃指数、血清SA 含量显著减少(P < 0.01)。结论:在裸鼠可耐受的剂量下,本发明药物对裸鼠原位移植的人胃低分化腺癌SGC-7901 以及人胃高分化腺癌MKN-28 均有明显的抗癌作用。
临床观察:
(1)一般资料
本发明人于2000年至今对800例患者进行临床观察治疗,年龄10到70岁不等,其中480例为山东癌症高发区普通人群,至今未有癌症患者出现,另420例为癌症患者。
(2)服用方法:一日两次,折合每日服用果蔬粉量为1.5-3g。
(3)疗效评定标准
治愈:症状体征完全消失;
有效:症状体征较前减轻;
无效:症状体征与治疗前无改善。
(4)治疗效果:
临床治愈420例,占88%;有效18例,无效32例,总有效率92.4%。
(5)典型病例:
王某,女,现年35 岁,潍坊潍城区人,于2001 年在潍坊人民医院检查诊断为肺癌,中晚期,当时医院给予的治疗意见是回家静养,经人介绍开始服用本发明的保健品1 年后,感到症状减轻,继续服用本发明产品并到医院继续治疗(化疗治疗)半年,康复,至今未复发。
赵某某,男,现年50岁,菏泽东明县人,与2010年在菏泽市立医院诊断为胃癌中期,接收化疗治疗三个月,效果不佳,之后开始服用本发明的产品,半年后治愈,继续服用三个月停止服用,至今未复发。
刘某,女,现年46岁,济南人,与2005年,在山东省立医院诊断为食道癌中期,服用本发明的产品5个月后逐渐停止服用,至今未复发。
韩某,男,现年78岁,济南人,于2009 年出现便血,经诊断为肠癌,随后经人介绍服用本发明的产品,经治疗半年后症状消失,且至今未复发。
Claims (3)
1.一种果蔬保健品,其特征在于:主要由以下重量份数的原料制备:
紫薯粉 10-70份、花椰菜粉 80-120份、南瓜粉30-80份、菠菜粉 10-40份、番茄粉 20-70份。
2.根据权利要求1所述的果蔬保健品的制备方法,其特征在于:包括以下步骤:将其原药材和/或其有效成分和/或药学上可接受的辅料一起制成散剂或袋泡剂、口服液、胶囊剂、片剂、丸剂或颗粒剂。
3.根据权利要求2所述的果蔬保健品的制备方法,其特征在于:将上述果蔬经粉碎、过筛、混合均匀,不加辅料直接灌胶囊或按常规方法制备保健药剂,或是加入适当辅料、并加入粘合剂制粒,干燥后灌装胶囊或加适量润滑剂后压成片剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310494195.5A CN103535725A (zh) | 2013-10-21 | 2013-10-21 | 一种果蔬保健品及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310494195.5A CN103535725A (zh) | 2013-10-21 | 2013-10-21 | 一种果蔬保健品及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103535725A true CN103535725A (zh) | 2014-01-29 |
Family
ID=49959887
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310494195.5A Pending CN103535725A (zh) | 2013-10-21 | 2013-10-21 | 一种果蔬保健品及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103535725A (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104997032A (zh) * | 2015-08-18 | 2015-10-28 | 天津可美科技发展有限公司 | 一种新型果蔬保健品及其制备方法 |
CN105747153A (zh) * | 2016-03-15 | 2016-07-13 | 李素琴 | 一种菠菜营养胶囊及其制作方法 |
CN106235307A (zh) * | 2016-07-28 | 2016-12-21 | 福建万亿店中店电子商务有限责任公司 | 一种肩周炎患者的硫酸软骨素杂粮羹 |
CN110663332A (zh) * | 2018-07-20 | 2020-01-10 | 湖南农业大学 | 一种提高蔬菜中硫苷和硒含量的叶面肥料及施用方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101147551A (zh) * | 2006-09-22 | 2008-03-26 | 天津中英纳米科技发展有限公司 | 一种番茄粉制品及其制备方法 |
WO2012012844A1 (en) * | 2010-07-29 | 2012-02-02 | The University Of Sydney | Vegetable and fruit juice powder |
CN102342313A (zh) * | 2010-08-02 | 2012-02-08 | 邓忠元 | 工业化生产防癌抗癌绿色微型食品 |
CN102860504A (zh) * | 2011-07-05 | 2013-01-09 | 邓忠元 | 实效防癌抗癌工业化系列食品组合 |
CN103127433A (zh) * | 2013-03-08 | 2013-06-05 | 陈印安 | 一种治疗肺癌的中药及其制备方法 |
-
2013
- 2013-10-21 CN CN201310494195.5A patent/CN103535725A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101147551A (zh) * | 2006-09-22 | 2008-03-26 | 天津中英纳米科技发展有限公司 | 一种番茄粉制品及其制备方法 |
WO2012012844A1 (en) * | 2010-07-29 | 2012-02-02 | The University Of Sydney | Vegetable and fruit juice powder |
CN102342313A (zh) * | 2010-08-02 | 2012-02-08 | 邓忠元 | 工业化生产防癌抗癌绿色微型食品 |
CN102860504A (zh) * | 2011-07-05 | 2013-01-09 | 邓忠元 | 实效防癌抗癌工业化系列食品组合 |
CN103127433A (zh) * | 2013-03-08 | 2013-06-05 | 陈印安 | 一种治疗肺癌的中药及其制备方法 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104997032A (zh) * | 2015-08-18 | 2015-10-28 | 天津可美科技发展有限公司 | 一种新型果蔬保健品及其制备方法 |
CN105747153A (zh) * | 2016-03-15 | 2016-07-13 | 李素琴 | 一种菠菜营养胶囊及其制作方法 |
CN106235307A (zh) * | 2016-07-28 | 2016-12-21 | 福建万亿店中店电子商务有限责任公司 | 一种肩周炎患者的硫酸软骨素杂粮羹 |
CN110663332A (zh) * | 2018-07-20 | 2020-01-10 | 湖南农业大学 | 一种提高蔬菜中硫苷和硒含量的叶面肥料及施用方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102742837A (zh) | 一种用于改善营养不良症状的保健食品及其制备方法 | |
CN105942498A (zh) | 具有治疗糖尿病作用的功能性营养食品组合及其制备方法 | |
CN106266700A (zh) | 一种沙棘组方袋泡型茶剂调配及制作方法 | |
WO2011060585A1 (zh) | 含有五色果蔬精华的咀嚼片剂及其制备方法 | |
CN103610035A (zh) | 一种海参营养口服液的制造方法 | |
CN103463457A (zh) | 铁皮石斛猴头菇复配咀嚼片及其制备方法 | |
KR20120026992A (ko) | 비만억제 활성과 혈당강하 효능이 있는 꾸지뽕 및 의이인을 포함하는 조성물 및 이의 용도 | |
JP6463504B2 (ja) | 発毛促進、脱毛緩和及び改善、血糖調節、胃腸障害の症状緩和及び改善用健康補助食品 | |
CN102085281A (zh) | 一种具有减肥作用的药物组合物 | |
CN103535725A (zh) | 一种果蔬保健品及其制备方法 | |
CN102273679A (zh) | 一种饮料的制作方法 | |
CN101507800A (zh) | 金线莲和南瓜复合降血糖保健品及其制备方法 | |
CN103734767B (zh) | 一种保健食品 | |
CN103055157B (zh) | 一种复方霍斛蓉芝颗粒及其生产工艺 | |
CN112741883A (zh) | 一种参苓健脾养血中药组合物及其制备方法 | |
CN103416651A (zh) | 一种西洋参绞股蓝冲剂 | |
CN103340919B (zh) | 一种灵芝精粉复方软胶囊及其制备方法 | |
CN113925172A (zh) | 一种适用于儿童的大鲵肽营养组合物 | |
CN108056461B (zh) | 一种黑木耳润肠功能咀嚼片及其制备方法 | |
CN1267141C (zh) | 一种复方全龟鳖铁皮枫斗养阴胶囊和冲剂制备方法 | |
KR20090021410A (ko) | 피로할 때 마시는 대추 침출 차 조성물과 그 제조방법 | |
KR100865900B1 (ko) | 복합생약추출물(occ-ⅰ) 또는 이의분말(occ-ⅱ)을 함유하는 당뇨병 예방 및 치료용조성물 | |
CN109289017A (zh) | 用于清理血管和血液的组合物及制备方法 | |
CN103610068A (zh) | 一种降血脂海参口服液的制造方法 | |
CN103610112A (zh) | 一种增强免疫力的海参口服液及其使用方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140129 |